M V Davi1, A Pia2, V Guarnotta3, G Pizza4, A Colao4, A Faggiano5. 1. Section of Endocrinology, Medicina Generale e Malattie Aterotrombotiche e Degenerative, Department of Medicine, University of Verona, Piazzale LA Scuro, Policlinico G.B. Rossi, 37134, Verona, Italy. mariavittoria.davi@ospedaleuniverona.it. 2. Internal Medicine I, Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Orbassano, Italy. 3. Section of Endocrinology, Biomedical Department of Internal and Specialist Medicine (DIBIMIS), University of Palermo, Palermo, Italy. 4. Endocrinology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. 5. Thyroid and Parathyroid Surgery Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale" IRCCS, Naples, Italy.
Abstract
BACKGROUND: Treatment of hyperinsulinemic hypoglycaemia (HH) is challenging due to the rarity of this condition and the difficulty of differential diagnosis. The aim of this article is to give an overview of the recent literature on the management of adult HH. METHODS: A search for reviews, original articles, original case reports between 1995 and 2016 in PubMed using the following keywords: hyperinsulinemic hypoglycaemia, insulinoma, nesidioblastosis, gastric bypass, autoimmune hypoglycaemia, hyperinsulinism, treatment was performed. RESULTS: One hundred and forty articles were selected and analysed focusing on the most recent treatments of HH. CONCLUSIONS: New approaches to treatment of HH are available including mini-invasive surgical techniques and alternative local-regional ablative therapy for benign insulinoma and everolimus for malignant insulinoma. A correct differential diagnosis is of paramount importance to avoid unnecessary surgical operations and to implement the appropriate treatment mainly in the uncommon forms of HH, such as nesidioblastosis and autoimmune hypoglycaemia.
BACKGROUND: Treatment of hyperinsulinemic hypoglycaemia (HH) is challenging due to the rarity of this condition and the difficulty of differential diagnosis. The aim of this article is to give an overview of the recent literature on the management of adult HH. METHODS: A search for reviews, original articles, original case reports between 1995 and 2016 in PubMed using the following keywords: hyperinsulinemic hypoglycaemia, insulinoma, nesidioblastosis, gastric bypass, autoimmune hypoglycaemia, hyperinsulinism, treatment was performed. RESULTS: One hundred and forty articles were selected and analysed focusing on the most recent treatments of HH. CONCLUSIONS: New approaches to treatment of HH are available including mini-invasive surgical techniques and alternative local-regional ablative therapy for benign insulinoma and everolimus for malignant insulinoma. A correct differential diagnosis is of paramount importance to avoid unnecessary surgical operations and to implement the appropriate treatment mainly in the uncommon forms of HH, such as nesidioblastosis and autoimmune hypoglycaemia.
Authors: Marianne Pavel; Eric Baudin; Anne Couvelard; Eric Krenning; Kjell Öberg; Thomas Steinmüller; Martin Anlauf; Bertram Wiedenmann; Ramon Salazar Journal: Neuroendocrinology Date: 2012-02-15 Impact factor: 4.914
Authors: Eric Raymond; Laetitia Dahan; Jean-Luc Raoul; Yung-Jue Bang; Ivan Borbath; Catherine Lombard-Bohas; Juan Valle; Peter Metrakos; Denis Smith; Aaron Vinik; Jen-Shi Chen; Dieter Hörsch; Pascal Hammel; Bertram Wiedenmann; Eric Van Cutsem; Shem Patyna; Dongrui Ray Lu; Carolyn Blanckmeister; Richard Chao; Philippe Ruszniewski Journal: N Engl J Med Date: 2011-02-10 Impact factor: 91.245
Authors: Geoffrey J Service; Geoffrey B Thompson; F John Service; James C Andrews; Maria L Collazo-Clavell; Ricardo V Lloyd Journal: N Engl J Med Date: 2005-07-21 Impact factor: 91.245
Authors: Beatrice C Lupsa; Angeline Y Chong; Elaine K Cochran; Maria A Soos; Robert K Semple; Phillip Gorden Journal: Medicine (Baltimore) Date: 2009-05 Impact factor: 1.889
Authors: N C Turner; S J Strauss; D Sarker; R Gillmore; A Kirkwood; A Hackshaw; A Papadopoulou; J Bell; I Kayani; C Toumpanakis; F Grillo; A Mayer; D Hochhauser; R H Begent; M E Caplin; T Meyer Journal: Br J Cancer Date: 2010-03-16 Impact factor: 7.640
Authors: C Mele; A Brunani; B Damascelli; V Tichà; L Castello; G Aimaretti; M Scacchi; P Marzullo Journal: J Endocrinol Invest Date: 2017-07-28 Impact factor: 4.256
Authors: Eduardo Lozano-Melendez; Mercedes Aguilar-Soto; Luis Eugenio Graniel-Palafox; Laura Elena Ceceña-Martínez; Rafael Valdez-Ortiz; Fabio Solis-Jimenez Journal: Case Rep Endocrinol Date: 2019-02-14
Authors: Tom J P Jansen; Sanne A M van Lith; Marti Boss; Maarten Brom; Lieke Joosten; Martin Béhé; Mijke Buitinga; Martin Gotthardt Journal: J Labelled Comp Radiopharm Date: 2019-08 Impact factor: 1.921